Clinically there is no Irbesartan and levamlodipine benzenesulfonate which is better, according to the condition of the choice of appropriate drugs to lower blood pressure treatment. Usually patients with primary hypertension or hypertension combined with type 2 diabetic nephropathy, can follow the doctor’s instructions to take the relevant dose of Irbesartan for long-term regular treatment, can achieve a more ideal effect of lowering blood pressure; and patients with hypertension, angina pectoris, can follow the doctor’s instructions to take levamlodipine benzenesulfonate for treatment, can also achieve the desired therapeutic effect. Irbesartan is suitable for the treatment of essential hypertension and type 2 diabetic nephropathy combined with hypertension. Adverse effects include tachycardia, vertigo, and sexual dysfunction. It is contraindicated in pregnant women from April through September of pregnancy and in nursing mothers. Levamlodipine besylate is indicated for the treatment of hypertension, chronic stable angina, and variant angina. Adverse reactions include dizziness, bradycardia, and dysesthesia. It is contraindicated in patients who are allergic to dihydropyridines or any of the ingredients in this product. If you need to take the above medication due to a medical condition, it is recommended to consult a doctor in a timely manner and choose the appropriate medication after a comprehensive assessment of your condition. Closely monitor the blood pressure and observe whether there are any uncomfortable symptoms during the use of the drug, and stop the drug in time to consult the doctor for treatment.